Status:
COMPLETED
Systemic Erythropoietin Injection in Patients Having Optic Atrophy
Lead Sponsor:
Alexandria University
Conditions:
Optic Atrophy
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy.
Detailed Description
The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy. The intervention is systemic erythropoietin injections (eprax 10000 IU subcutane...
Eligibility Criteria
Inclusion
- Post papilledemic optic atrophy patients
Exclusion
- Refuse to give an informed consent
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04680143
Start Date
September 1 2020
End Date
March 30 2021
Last Update
July 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Faculty of Medicine
Alexandria, Egypt